FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy
The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
UAE Begins Local Manufacturing of Hemodialysis Solutions for the First Time
Mubadala Bio has launched the UAE's first locally manufactured hemodialysis concentrate solutions…
Collaboration to Advance Healthcare Research and Workforce Development
A strategic MoU has been signed to strengthen the UAE pharmaceutical sector…
ADAP Crisis Task Force Strikes Deal to Widen Access to New HIV Pill
Merck has partnered with the ADAP Crisis Task Force to expand access…
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
GSK completes acquisition of 35Pharma Inc.
GSK plc has completed the acquisition of 35Pharma Inc., adding HS235, a…
GSK to Acquire RAPT Therapeutics, Advancing Long-Acting IgE Therapy for Food Allergy Patients
GSK has agreed to acquire RAPT Therapeutics, adding a long-acting anti-IgE therapy…
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk announced that Maziar Mike Doustdar has been appointed as president…
